Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul;52(7):772-9.
doi: 10.1002/mnfr.200700081.

Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics

Affiliations

Gauging the clinical significance of P-glycoprotein-mediated herb-drug interactions: comparative effects of St. John's wort, Echinacea, clarithromycin, and rifampin on digoxin pharmacokinetics

Bill J Gurley et al. Mol Nutr Food Res. 2008 Jul.

Abstract

Concomitant administration of botanical supplements with drugs that are P-glycoprotein (P-gp) substrates may produce clinically significant herb-drug interactions. This study evaluated the effects of St. John's wort and Echinacea on the pharmacokinetics of digoxin, a recognized P-gp substrate. Eighteen healthy volunteers were randomly assigned to receive a standardized St. John's wort (300 mg three times daily) or Echinacea (267 mg three times daily) supplement for 14 days, followed by a 30-day washout period. Subjects were also randomized to receive rifampin (300 mg twice daily, 7 days) and clarithromycin (500 mg twice daily, 7 days) as positive controls for P-gp induction and inhibition, respectively. Digoxin (Lanoxin 0.25 mg) was administered orally before and after each supplementation and control period. Serial digoxin plasma concentrations were obtained over 24 h and analyzed by chemiluminescent immunoassay. Comparisons of area under the curve (AUC)((0-3)), AUC((0-24)), elimination half-life, and maximum serum concentration were used to assess the effects of St. John's wort, Echinacea, rifampin, and clarithromycin on digoxin disposition. St. John's wort and rifampin both produced significant reductions (p < 0.05) in AUC((0-3)), AUC((0-24)), and C(max), while clarithromycin increased these parameters significantly (p < 0.05). Echinacea supplementation did not affect digoxin pharmacokinetics. Clinically significant P-gp-mediated herb-drug interactions are more likely to occur with St. John's wort than with Echinacea.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Digoxin concentration-time profiles (0-6 hours) before and after each supplementation/drug phase. (A) pre- and post-clarithromycin; (B) pre- and post-Echinacea; (C) pre- and post-rifampin; (D) pre- and post-St. John's wort. Black squares = pre-experimental mean serum digoxin concentrations. Gray circles = post-experimental mean serum digoxin concentrations. Error bars = s.d.

Similar articles

Cited by

References

    1. Cupp MJ. Herbal remedies: adverse effects and drug interactions. Am. Fam. Phys. 1999;59:1239–1244. - PubMed
    1. Ioannides C. Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica. 2002;32:451–478. - PubMed
    1. Zhou S, Gao Y, Jiang W, Huang M, et al. Interactions of herbs with cytochrome P450. Drug Metab. Rev. 2003;35:35–98. - PubMed
    1. Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab. Rev. 2004;36:57–104. - PubMed
    1. Mills E, Wu P, Johnston BC, Galliacano K. Natural health product-drug interactions: a systematic review of clinical trials. Ther. Drug Monit. 2005;27:549–557. - PubMed

Publication types

MeSH terms